OncoVista Innovative Therapies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OVIT research report →
Price Chart
About the company
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The firm produces drug discovery, registration strategies, and emerging technologies.
- CEO
- Alexander L. Weis
- IPO
- 2007
- Employees
- 2
- HQ
- San Antonio, TX, US
Get TickerSpark's AI analysis on OVIT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.36K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -0.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 57.94%
- ROIC
- 53.54%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-2,545,803
- Net Income
- $-2,544,393-75.5%
- EPS
- $-0.12-71.4%
- OCF Growth
- +50.2%
- FCF Growth
- +50.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.92
- RSI (14)
- 34
- Avg Volume
- 161
No earnings-call transcripts are available for OVIT yet.
- Free Float
- 100.0%
- Shares Outstanding
- 23.56M
- Float Shares
- 23.56M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 3, 11 | Moloney Michael | other | 0 |
| Feb 3, 11 | Moloney Michael | other | 450,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our OVIT coverage
Recent articles, reports, and earnings notes.
No research on OVIT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OVIT report →